A Multicenter Cross-sectional Study of Cardiac Ultrasound Phenotypes in Patients With Sepsis
Launched by FUJIAN PROVINCIAL HOSPITAL · Dec 6, 2021
Trial Information
Current as of July 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • - All patients with sepsis or septic shock who conform to Sepsis 3.0 diagnostic criteria
- Exclusion Criteria:
- • 1. Patients with preexisting chronic heart disease such as cardiomyopathy, chronic pulmonary heart disease, severe cardiac valve disease, coronary heart disease, congenital heart disease, pericardial disease, etc. and with cardiac function ≥ grade III (NYHA classification) prior to sepsis.
- • 2. End-stage malignancies.
- • 3. Severe trauma.
- • 4. Pregnancy.
- • 5. Patients for whom transthoracic echocardiography data are not available.
About Fujian Provincial Hospital
Fujian Provincial Hospital is a leading medical institution in Fujian Province, China, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital integrates cutting-edge medical technology and multidisciplinary expertise to enhance patient care and contribute to the global medical community. With a focus on improving treatment outcomes across various specialties, Fujian Provincial Hospital adheres to the highest ethical standards and regulatory guidelines, ensuring the safety and well-being of participants while fostering advancements in medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Fuzhou, Fujian, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials